Navigation Links
PAREXEL Advances Early Phase CNS Research Capabilities With Leading Medical Imaging Technology
Date:11/22/2011

oking statements in this release involve a number of risks and uncertainties.  The Company's actual future results may differ significantly from the results discussed in the forward-looking statements contained in this release.  Important factors that might cause such a difference include, but are not limited to, risks associated with: actual operating performance; actual expense savings and other operating improvements resulting from recent and anticipated restructurings, including the anticipated additional restructuring charges of approximately $4 million in the second quarter of Fiscal Year 2012; the loss, modification, or delay of contracts which would, among other things, adversely impact the Company's recognition of revenue included in backlog; the Company's dependence on certain industries and clients; the Company's ability to win new business, manage growth and costs, and attract and retain employees; the Company's ability to complete additional acquisitions and to integrate newly acquired businesses or enter into new lines of business; the impact on the Company's business of government regulation of the drug,  medical device and biotechnology industry; consolidation within the pharmaceutical industry and competition within the biopharmaceutical services industry; the potential for significant liability to clients and third parties; the potential adverse impact of health care reform; and the effects of exchange rate fluctuations and other international economic, political, and other risks.  Such factors and others are discussed more fully in the section entitled "Risk Factors" of the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2011 as filed with the SEC on November 9, 2011, which "Risk Factors" discussion is incorporated by reference in this press release.  The Company specifically disclaims any obligation to update these forward-looking statements in the future.  These forward-looking statements
'/>"/>
SOURCE PAREXEL International Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. UCB and PAREXEL Sign Strategic Partnership Agreement
2. PAREXEL International to Present at Lazard Capital Markets Healthcare Conference and Citi Small/Mid Cap Conference
3. PAREXEL Commercialization Experts to Present Best-Practice Approaches for Demonstrating Product Value at ISPOR Annual European Congress
4. PAREXEL Reports First Quarter Fiscal Year 2012 Financial Results
5. PAREXEL Expands Commercialization Capabilities With Dedicated Team to Help Biopharma Companies Demonstrate Product Value
6. New PAREXEL Podcast Series to Deliver Clinical Development and Commercialization Thought Leadership
7. PAREXEL and National University of Singapore Establish Program in Singapore to Meet Increasing Demand in Asia for Clinical Research Talent
8. PAREXEL Announces Date of First Quarter Fiscal Year 2012 Earnings Release and Conference Call
9. Experts to Provide Successful Strategies for Global Biopharmaceutical Development and Commercialization at PAREXEL Tokyo Seminar
10. PAREXEL International Reports Fourth Quarter and Fiscal Year 2011 Results
11. PAREXEL Achieves 100th Asian Ethnobridging Study Milestone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)...  United Therapeutics Corporation (NASDAQ: UTHR ) ... District of New Jersey has ... Sandoz, Inc. regarding United Therapeutics, Remodulin ® product.  In ... U.S. Patent No. 6,765,117 is both valid and enforceable ... generic product until the expiration of that patent in ...
(Date:8/29/2014)... , August 29, 2014 ... Market by Product & Services (Equipment, Reagent, Primer, ... Application (Diagnostics, PCR, QPCR, Gene Synthesis, NGS, DNA, ... MarketsandMarkets, the global Oligonucleotide Synthesis Market is expected ... Million in 2014, growing at a CAGR of ...
(Date:8/29/2014)...  Unilife Corporation ("Unilife" or "Company") (NASDAQ: ... to release its financial results for the fiscal 2014 ... market trading ends on Tuesday, September 9, 2014. ... 4:30 p.m. U.S. EDT on Tuesday, September 9, 2014 ... the Company,s financial results, commercial partnerships, and future outlook.  ...
Breaking Medicine Technology:District Court Decision Received In Remodulin Patent Case 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 3Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 4Unilife Corporation to Announce Financial Results for Fiscal Year 2014 Fourth Quarter and Year End on Tuesday, September 9, 2014 2
(Date:9/2/2014)... Squared, a well-known Buy One, Give One company, is ... For every toothbrush purchased, Smile Squared gives one to ... by my wife and me after volunteering at a ... Smile Squared. “There, we saw children who had preventable ... same children didn't own a toothbrush. We wanted to ...
(Date:9/2/2014)... fact that mechanical heart valves increase risks during and ... ROPAC registry presented for the first time today in ... W. Roos-Hesselink, co-chair with Professor Roger Hall of the ... pregnant women with a mechanical heart valve died and ... Of Pregnancy And Cardiac disease (ROPAC) is an ongoing ...
(Date:9/2/2014)... September 02, 2014 Attorney Robert M. ... 2015 "Lawyer of the Year" for Medical Malpractice Law ... Meyer PC, Boston, and has been selected for inclusion in ... one lawyer in each practice area and designated metropolitan area ... particularly impressive voting averages received during the peer-review assessments. ...
(Date:9/2/2014)... 2014 During the fall season, before ... the winter months to prevent costly damage later on. ... company, suggests these fall preventative home maintenance tips. ... frequently throughout fall to prevent build up of leaves ... rot problems, pest infestations, wet basements, foundation damage and ...
(Date:9/1/2014)... web hosting provides a Windows based server environment. There ... and the new demand has resulted in an increase ... a variety of different services at very affordable prices. ... web hosting suppliers from the USA and announced that ... webmasters who want to buy high quality WordPress hosting ...
Breaking Medicine News(10 mins):Health News:Smile Squared's Colorful Buy One, Give One Toothbrush Now Available in Schnucks Stores 2Health News:Mechanical heart valves increase pregnancy risk 2Health News:Mechanical heart valves increase pregnancy risk 3Health News:Robert Higgins Named 2015 Best Lawyers® "Lawyer of the Year" in Boston 2Health News:Northern Virginia Real Estate Company Pasquali Realty Group Suggests These Maintenance Tips for Homeowners This Fall 2Health News:SEO Hosting Review Site Top10BestSEOHosting.com: Best Windows Web Hosting Suppliers From the USA Now Unveiled 2
... lifestyle characteristics can be linked to different invasive breast ... in the open access journal Breast Cancer Research ... the condition are associated with different kinds of tumor. ... California, led a team of researchers who used data ...
... Texas, ophthalmologists recommend ten simple steps to reduce your chance ... More than 20 million Americans suffer from severe vision loss. ... simple steps that everyone can take to help their eyes ... in the future. May is Healthy Vision Month and through ...
... As a health care practitioner, Trina Hammack knew ... ovarian cancer, she knew her prognosis was bleak. ... offering effective new treatments for ovarian cancer. ... of Americans diagnosed with cancer will travel to Mexico ...
... 2009NEW YORK, May 21 New York Blood ... Valley, Brooklyn / Staten Island, and New Jersey are facing ... safe blood supply for hospital patients, including: Number One: ... , Some high school blood drives have been canceled, and ...
... moms linked to higher stress levels in adolescence , , THURSDAY, ... excessive time in child-care facilities or who had insensitive mothers ... a long-term study suggests. , The conclusion is based on ... Development , that by age 15 these children are ...
... gene showed fewer signs of condition , , THURSDAY, May 21 ... allergy-induced asthma has been identified by U.S. researchers, who said ... disease. , The researchers found that mice without the ... "When compared to normal mice, those lacking the gene for ...
Cached Medicine News:Health News:Top 10 Tips to Save Your Vision 2Health News:Top 10 Tips to Save Your Vision 3Health News:Top 10 Tips to Save Your Vision 4Health News:The Diagnosis Every Woman Dreads - Ovarian Cancer 2Health News:The Diagnosis Every Woman Dreads - Ovarian Cancer 3Health News:It's Summer; Patients Need Us to Donate Blood! 2Health News:Teen Stress May Have Roots in First Three Years of Life 2
The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems....
The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems....
Quatroloc Revision Hip System...
Exactech's AcuMatch C-Series (Cemented Femoral Stem) is designed to provide solutions to the problems which compromise both the short and long term successful outcome of cemented hip arthroplasty....
Medicine Products: